Exogene is a biotechnology startup accelerating the discovery of T-cell-receptor(TCR)-based cell therapies for otherwise untreatable solid tumors. They are building a machine learning platform to comprehensively screen TCRs from tumor-infiltrating lymphocytes (TILs) derived from cancer patients to rapidly find new cancer targets and target-specific TCRs for therapeutic application. Using novel wet-lab TCR screening technologies (yeast display combined with mammalian display), Exogene is able to generate data for their machine learning platform in-house by screening billions of TCR-target interactions.
Location: United Kingdom, England, London
Employees: 1-10
Investors 3
| Date | Name | Website |
| 12.06.2021 | Creative D... | creativede... |
| - | Entreprene... | joinef.com |
| - | Unruly Cap... | unrulycap.... |
Mentions in press and media 1
| Date | Title | Description |
| 04.11.2021 | 10 new data-driven health companies selected for KQ Labs accelerator programme | 10 innovative start-up companies working at the interface of biomedical and data science are to receive personalised mentoring and coaching as part of the KQ Labs accelerator programme, run by the Francis Crick Institute and funded by the m... |